Johnson & Johnson Stock Facing Negative Catalysts Ahead of Q2 Results

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

JNJ stock is facing multiple negative catalysts, including lawsuits and regulatory risk. Investors should avoid Johnson & Johnson stock.

The post Johnson & Johnson Stock Facing Negative Catalysts Ahead of Q2 Results appeared first on InvestorPlace.

• 2 Toxic Pot Stocks You Should Avoid
• 7 Dependable Dividend Stocks to Buy
• 10 Stocks Driving the Market to All-Time Highs (And Why)
• 7 Short Squeeze Stocks With Big Upside Potential